Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: Inhibition by proliferating osteoblasts and osteosarcoma cells

Journal of Cellular Biochemistry

Volumn 66, Issue 2, 1997, Pages 141-152

  Smith, Elisheva ^a   Frenkel, Baruch ^a   MacLachlan, Timothy K ^b   Giordano, Antonio ^b   Stein, Janet L ^a   Lian, Jane B ^a   Stein, Gary S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cyclin dependent kinase inhibitors; Cyclin E associated kinase; Differentiation; Osteoblasts; RB related proteins

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIPLOIDY; ENZYME INHIBITION; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; HEAT; OSTEOBLASTS; OSTEOSARCOMA; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030811548     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970801)66:2<141::AID-JCB2>3.0.CO;2-Q     Document Type: Article

References (60)

1. Bortell R, Owen TA, Shalhoub V, Heinrichs A, Aronow MA, De Luca H, Stein JL, Lian JB, Stein GS (1993): Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein/DNA interactions at promoter regulatory elements. Proc Natl Acad Sci USA 90:2300-2304.
2. Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL, Phillips RA (1995): Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol 15:3256-3265.
3. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K, Akiyama T (1995): Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J Biol Chem 270:23031-23037.
4. Draetta G, Beach D (1988): Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54:17-26.
5. Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D (1989): cdc2 protein kinase is complexed with both cyclin A and B: Evidence for proteolytic inactivation of MPF. Cell 56:829-838.
6. Dulic' V, Lees E, Reed SI (1992): Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1960.
7. Dulic' V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI (1994): p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
8. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993): WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
9. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM (1993): Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
10. Firpo EJ, Koff A, Solomon MJ, Roberts JM (1994): Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14:4889-4901.
11. Giordano A, Whyte P, Harlow E, Franza BR Jr, Beach D, Draetta G (1989): A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell 58:981-990.
12. Gu Y, Turck CW, Morgan DO (1993): Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
13. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993): The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
14. Hatakeyama M, Brill JA, Fink GR, Weinberg RA (1994): Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev 8:1759-1771.
15. Hengst L, Reed SI (1996): Translational control of p27KIP1 accumulation during the cell cycle. Science 271:1861-1864.
16. Hengst L, Dulic' V, Slingerland JM, Lees E, Reed SI (1994): A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci, USA 91:5291-5295.
17. Hinds PW, Mittnacht S, Dulic' V, Arnold A, Reed SI, Weinberg RA (1992): Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
18. Hunter T, Pines J (1994): Cyclins and Cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582.
19. Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ (1993): Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342.
20. King RW, Jackson PK, Kirschner MW (1994): Mitosis in transition. Cell 79:563-571.
21. Kiyokawa H, Richon VM, Rifkind RA, Marks PA (1994): Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14:7195-7203.
22. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM (1991): Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217-1228.
23. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM (1992): Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
24. Kranenburg O, de Groot RP, Van der Eb AJ, Zantema A (1995): Differentiation of P19EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10:87-95.
25. Lees E, Faha B, Dulic' V, Reed SI, Harlow E (1992): Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1875.
26. Lew DJ, Dulic' V, Reed SI (1991): Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66:1197-1206.
27. Li Y, Jenkins CW, Nichols MA, Xiong Y (1994): Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
28. Loyer P, Glaise D, Cariou S, Baffet G, Meijer L, Guguen-Guillouzo C (1994): Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem 269:2491-2500.
29. MacLachlan TK, Sang N, Giordano A (1995): Cyclins, cyclin-dependent kinases and cdk inhibitors: Implication in cell cycle control and cancer. Crit Rev Eukaryotic Gene Expression 5:127-156.
30. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995): p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNAdamage. Genes Dev 9:935-944.
31. Majeska RJ, Rodan SB, Rodan GA (1980): Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494-1503.
32. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ (1991): Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
33. Matsushime H, Ewen ME, Strom DK, Kato J-Y, Hanks SK, Roussel MF, Sherr CJ (1992): Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
34. Miyajima M, Nornes HO, Neuman T (1995): Cyclin E is expressed in neurons and forms complexes with cdk5. NeuroReport 6:1130-1132.
35. Morgan, DO (1995): Principles of CDK regulation. Nature 374:131-134.
36. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994): Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98.
37. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massagué J, Crabtree G, Roberts J (1994): Interleukin-2-mediated elimination of p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
38. Nurse P (1994): Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
39. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990): Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
40. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G (1992): Cyclin A is required at two points in the human cell cycle. EMBO J 11:961-971.
41. Pines J, Hunter T (1989): Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833-846.
42. Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A (1994): p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-? and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
43. Quelle DE, Ashmun RA, Shurtleff SA, Kato J-Y, Bar-Sagi D, Roussel MF, Sherr CJ (1993): Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571.
44. Rao SS, Khotz DS (1995): Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor b. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem 270:4093-4100.
45. Resnitzky D, Gossen M, Bujard H, Reed SI (1994): Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679.
46. Sheikh MS, Li X-S, Chen J-C, Shao Z-M, Ordonez JV, Fontana JA (1994): Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415.
47. Sherr CJ (1994): G1 phase progression: Cycling on cue. Cell 79:551-555.
48. Sherr CJ, Roberts JM (1995): Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
49. Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI (1994): A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor b-arrested epithelial cells. Mol Cell Biol 14:3683-3694.
50. Smith E, Frenkel B, Schlegel R, Giordano A, Lian JB, Stein JL, Stein GS (1995): Expression of cell cycle regulatory factors in differentiating osteoblasts: Post-proliferative upregulation of cyclins B and E. Cancer Res 55:5019-5024.
51. Stein GS, Lian JB, Stein JL, van Wijnen AJ, Montecino M (1996): Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593-629.
52. Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A (1995): The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691-1698.
53. Tam SW, Belinsky GS, Schlegel R (1995): Premature expression of cyclin B sensitizes human HT1080 cells to caffein-induced premature mitosis. J Cell Biochem 59:339-349.
54. Tsai L-H, Harlow E, Meyerson M (1991): Isolation of the human cdk2 gene that encodes the cyclin A-and adenovirus E1A-associated p33 kinase. Nature 353:174-177.
55. van den Ent FMI, van Wijnen AJ, Last TJ, Bortell R, Stein JL, Lian JB, Stein GS (1993): Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: Reciprocal regulation of cell cycle controlled and bone-related genes. Cancer Res 53:2399-2409.
56. van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL, Rudkin BB (1996): Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: Dissection of the neurotrophic response from the anti-mitogenic response. Oncogene 12:1347-1356.
57. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993): p21 is a universal inhibitor of cyclin kinases. Nature 366:701-794.
58. Yan G.-Z, and Ziff EB (1995): NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinase and induction of cyclin D1. J Neurosci 15:6200-6212.
59. Zhang H, Hannon GJ, Beach D (1994): p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750-1758.
60. Zhu L, Harlow E, Dynlacht BD (1995): p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9:1740-1752.